ACT-CSP for Family Caregivers of Palliative Care Patients
Launched by THE HONG KONG POLYTECHNIC UNIVERSITY · Jan 14, 2024
Trial Information
Current as of July 07, 2025
Withdrawn
Keywords
ClinConnect Summary
This study will employ a pilot randomized controlled trial recruiting caregivers of palliative care patients to receive either a 3-week acceptance and commitment therapy for supporting caregiver programme (ACT-CSP) plus usual care (n = 15) or usual care only (n = 15). The components of acceptance and commitment therapy process will be emphasized in the intervention programme, which include perspective taking, self-as-context and defusion (i.e. recognizing worry thoughts as thoughts only), identifying values and acceptance of present-moment experience with respect to the values, and committe...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged ≥ 18;
- • Self- or patient-identified as a family caregiver of an adult patient receiving palliative care at the study site
- • Have been taking care of the patient in the past 3 months;
- • Able to communicate in Cantonese at the time of recruitment;
- • Have access to internet and videoconferencing device such as mobile phone;
- • Have caregiver burden as measured by Caregiver Strain Index (CSI) ≥ 7.
- Exclusion Criteria:
- • Mentally incompetent (Mini-Mental State Examination (MMSE) \< 23),
- • Participating in regular psychosocial interventions.
About The Hong Kong Polytechnic University
The Hong Kong Polytechnic University (PolyU) is a leading institution in applied research and education, dedicated to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, PolyU focuses on conducting rigorous and ethically sound research to enhance understanding of medical interventions and improve patient outcomes. The university leverages its multidisciplinary expertise, state-of-the-art facilities, and collaboration with industry partners to facilitate groundbreaking studies that address pressing health challenges. Committed to fostering an environment of academic excellence, PolyU aims to translate research findings into practical solutions that benefit society and contribute to the global advancement of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Doris YP Leung
Principal Investigator
The Hong Kong Polytechnic University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported